Diabetes Increases the Risk of Chronic Liver Disease and Hepatocellular Carcinoma

Gastroenterology

Volumn 126, Issue 2, 2004, Pages 460-468

  El Serag, Hashem B ^a,c   Tran, Thomas ^a   Everhart, James E ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CHRONIC LIVER DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 0842321807     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.10.065     Document Type: Article

References (51)

1. Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002;36:227-242.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
3. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000;160:3227-3230.
4. Ruhl CE, Everhart JE. Determinants of the association of over-weight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003;124:71-79.
5. Greeve M, Ferrell L, Kim M, Combs C, Robert J, Ascher N, Wright TL. Cirrhosis of undefined pathogenesis: absence of evidence for unknown or autoimmune processes. Hepatology 1993;17:593-598.
6. Lee R. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989;20:594-598.
7. Powell E, Cooksley W, Hanson R, Searle J, Halliday J, Powell L. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
8. Angulo P, Keach J, Batts K, Lindor K. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-1362.
9. Di Bisceglie AM, Carithers RL Jr, Gores GL. Hepatocellular carcinoma. Hepatology 1998;28:1161-1165.
10. El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans. Am J Gastroenterol 2001;96:2462-2467.
11. Matteoni C, Younossi Z, Gramlich T, Bopari N, Liu Y, McCullough A. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.
12. Marchesini G, Brizi M, Morselli-Labate A, Bianchi G, Bugianesi E, McCullough A, Forlani G, Melachionda N. Association of non-alcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-455.
13. Belfiore F, Iannello S. Insulin resistance in obesity: metabolic mechanisms and measurement methods. Mol Genet Metab 1998;65:121-128.
14. Falck-Ytter, Younossi Z, Marchesini G, McCullough A. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001;21:17-26
15. Cotrim H, Parana R, Braga E, Lyra L. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history? Am J Gastroenterol 2000;95:3018-3019.
16. Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatopathtis. Pathol Int 2001;51:127-131.
17. Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Yayashi N, Takasaki K, Lugwig J. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002;37:154-160.
18. Kessler II. Cancer mortality among diabetics. J Natl Cancer Inst 1970;44:2051-2055.
19. Ragozzino M, Melton LJ III, Chu CP, Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 1982;35:13-19.
20. Lu SN, Lin TM, Chen CJ, Chen JS, Liaw YF, Chang WY, Hsu ST. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988;62:2051-2055.
21. Kingston ME, Ali MA, Atiyeh M, Donnelly RJ. Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology 1984;87:688-694.
22. Lawson DH, Gray JM, McKillop C, Clarke J, Lee FD, Patrick RS. Diabetes mellitus and primary hepatocellular carcinoma. Q J Med 1986;61:945-955.
23. La Vecchia C, Negri E, D'Avanzo B, Boyle P, Franceschi SD. Medical history and primary liver cancer. Cancer Res 1990;50:6274-6277.
24. Yu MC, Tong MJ, Govindarajan S, Henderson BE. Non-viral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-1826.
25. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, Persson I. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991;2:307-314.
26. La Vecchia C, Negri E, Franceschi SD, D'Avanzo B, Boyle P. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994;70:950-953.
27. Adami HO, Chow WH, Nyren O, Berne C, Linet MS, Ekbom A, Wolk A, McLaughlin JK, Fraumeni JF. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996;88:1472-1477.
28. La Vecchia C, Negri E, DeCarli A, Franceschi SD. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997;73:204-207.
29. Braga C, La Vecchia C, Negri E, Franceschi S. Attributable risks for hepatocellular carcinoma in Northern Italy. Eur J Cancer 1997;33:629-634.
30. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, Borch-Johnsen K, Olsen JH. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89:1360-1365.
31. Lagiou P, Kuper H, Stuver S, Tzonou A, Trichopoulos D, Adami HO. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 2000;92:1096-1099.
32. Fujino Y, Mizoue T, Tokui N, Yoshimura T. Prospective study of diabetes mellitus and liver cancer in Japan. Diabetes Metab Res Rev 2001;17:374-379.
33. Tazawa J, Maeda M, Nakagawa M, Ohbayashi H, Kusano F, Yamane M, Sakai Y, Suzuki K. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig Dis Sci 2002;47:710-715.
34. Hassan M, Hwang L, Hatten C, Swaim M, Li D, Abbruzzese J, Beasley P, Patt Y. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002;36:1206-1213.
35. Department of Health and Human Services. The international classification of diseases, 9th rev., clinical modification: ICD-9-CM. 3rd ed. Volume 1. Diseases: tabular list. Washington, DC: Government Printing Office, March 1989. (DHHS publication no. (PHS) 89-1260.).
36. Boyko EJ, Koepsell TD, Gaziano JM, Homer RD, Feussner JR. US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol 2000;151:307-314.
37. Page WF. VA mortality reporting for World War II army veterans. Am J Epidemiol 1992;82:124-125.
38. Page WF, Mahan CM, Kang HK. Vital status ascertainment through the files of the department of Veterans Affairs and the social security administration. Ann Epidemiol 1996;6:102-109.
39. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use of the ICD-9-CM in administrative databases. J Clin Epidemiol 1992;45:613-619.
40. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 1992;15:815-819.
41. Poonawala A, Nair S, Thuluvath P. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000;32:689-692.
42. Amarapurkar D, Das H. Chronic liver disease in diabetes mellitus. Trop Gastroenterol 2002;23:3-5.
43. Megyesi C, Samols E, Matks V. Glucose tolerance and diabetes in chronic liver disease. Lancet 1967;2:1051-1056.
44. Conn H, Schreiber W, Elkington SG, Johnson TR. Cirrhosis and diabetes: Increased incidence of diabetes in patients with Laennec's cirrhosis. Am J Dig Dis 1969;14:837-852.
45. Muting D, Wohlgemuth D, Dorsett R. Liver cirrhosis and diabetes mellitus. Geriatrics 1969;24:91-99.
46. Shmueli E, Record C, Alberti K. Liver disease, carbohydrate metabolism and diabetes. Bailleres Clin Endocrinol Metab 1992;6:719-743.
47. Kashner TM. Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care 1998;36:1324-1336.
48. Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria in steatohepatitis. Sem Liver Dis 2001;21:57-69.
49. Chitturi S, Farrell G. Etiopathogenesis of nonalcoholic steatohepatitis. Sem Liver Dis 2001;21:27-41.
50. Fong D, Nehra V, Lindor K, Buchman AL. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology 2000;3:3-10.
51. National Center for Health Statistics. Health, United States. Washington DC: Government Printing Office, 1998.